ALYSSA BURCIAGO: Open Payments
NPI 1215648563 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 23 payments from 9 companies in 2025. Trend: 2023 $22 · 2024 $77 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $96 |
| ABBVIE INC. | 4 | $92 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| PFIZER INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $24 |
Products named: AUSTEDO XR, Ozempic, QULIPTA, Wegovy, INGREZZA, AIRSUPRA, NURTEC ODT, Cologuard Collection Kit.
Industry payments across CO — which companies pay providers there.
